Evaxion Biotech A/S - American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share (EVAX)

Historical Holders from Q4 2023 to Q3 2025

Symbol
EVAX on Nasdaq
CUSIP
29970R204
Type / Class
Equity / American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share
Shares outstanding
316M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
1.21M
Holdings value
$4.57M
Number of holders
2
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Evaxion Biotech A/S - American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share (EVAX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Merck & Co., Inc. 19.96% $106M 63M Merck & Co., Inc. Jan 31, 2025

Institutional Holders of Evaxion Biotech A/S - American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share (EVAX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 1.21M $4.57M $3.63 2
2025 Q2 1.21M $2.97M $2.23 2
2025 Q1 1.21M $2.25M +$1.02M $1.68 2
2024 Q4 806K $682K -$278K $0.85 9
2024 Q3 548K $1.71M +$291K $3.11 8
2024 Q2 453K $1.31M +$206K $2.89 6
2024 Q1 381K $1.22M +$1.21M $3.20 6
2023 Q4 10K $6.86K +$6.86K $0.69 1